XML 20 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Consolidated net income $ 707 $ 532
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation, depletion and amortization 514 505
Deferred income tax expense (benefit) 57 42
Interest accretion on landfill and environmental remediation liabilities 33 32
Provision for bad debts 10 9
Equity-based compensation expense 30 26
Net gain on disposal of assets (10) (10)
(Gain) loss from divestitures, asset impairments and other, net (2) (3)
Equity in net losses of unconsolidated entities, net of dividends 19 11
Change in operating assets and liabilities, net of effects of acquisitions and divestitures:    
Receivables 176 138
Other current assets (45) (51)
Other assets (4) 22
Accounts payable and accrued liabilities (102) (145)
Deferred revenues and other liabilities (16) (64)
Net cash provided by operating activities 1,367 1,044
Cash flows from investing activities:    
Acquisitions of businesses, net of cash acquired (11) (34)
Capital expenditures (668) (660)
Proceeds from divestitures of businesses and other assets, net of cash divested 15 11
Other, net (91) (95)
Net cash used in investing activities (755) (778)
Cash flows from financing activities:    
New borrowings 4,412 6,885
Debt repayments (4,570) (6,548)
Common stock repurchase program (250) (350)
Cash dividends (307) (289)
Exercise of common stock options 32 12
Tax payments associated with equity-based compensation transactions (48) (28)
Other, net (6) (1)
Net cash used in financing activities (737) (319)
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents (2)  
(Decrease) increase in cash, cash equivalents and restricted cash and cash equivalents (127) (53)
Cash, cash equivalents and restricted cash and cash equivalents at beginning of period 552 445
Cash, cash equivalents and restricted cash and cash equivalents at end of period $ 425 $ 392